Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07869732 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to evaluate the safety, tolerability, and blood levels of (Z)-endoxifen in girls with McCune-Albright Syndrome that have peripheral precocious puberty. The main question it aims to answer \[is/are\]: Are there any safety concerns? Is there any evidence of efficacy? There is no comparison group. Participants will: * take a capsule once a day for 3 months; * have doctor visits (tele-health and in-person); * blood samples collected; and * complete questionnaires
Trial Details
NCT Number NCT07869732
Lead Sponsor Atossa Therapeutics, Inc.
Collaborators: National Institute of Dental and Craniofacial Research (NIDCR)
Conditions
(from sponsor)		 Precocious Puberty, Gonadotropin-dependent
Related terms Puberty, Precocious
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov